/

Other

/

Janssen-Cilag Pharma GmbH

Janssen-Cilag Pharma GmbH

Janssen-Cilag Pharma GmbH

Verified Nov 2026

Other

·

Vienna, Vienna

·

Since

Janssen-Cilag Pharma GmbH, headquartered in Vienna, Austria, is a pharmaceutical division of Johnson & Johnson with 10,000–50,000 employees and over $10 billion in revenue. The company develops medicines across oncology, immunology, neuroscience, cardiovascular and metabolism, pulmonary hypertension, and retina therapies. In 2026, the company secured pharmaceutical supply contracts with Spanish health authorities.

Janssen-Cilag Pharma GmbH

Verified Nov 2026

AT A GLANCE

Founded

Headquarters

Vienna, Vienna

Employees

10,000-50,000

Ownership

Janssen-Cilag Pharma GmbH at a glance

Revenue

$10B+

Est. band

Employees

10,000-50,000

Headquarters

Vienna, Vienna

Certifications

ISO 9001

Industries

Automotive

Electric Vehicles

Medical

Overview

Janssen-Cilag Pharma GmbH, headquartered in Vienna, Austria, is a pharmaceutical division of Johnson & Johnson with 10,000–50,000 employees and over $10 billion in revenue. The company develops medicines across oncology, immunology, neuroscience, cardiovascular and metabolism, pulmonary hypertension, and retina therapies. In 2026, the company secured pharmaceutical supply contracts with Spanish health authorities.

At a glance

Attribute

Detail

Headquarters

Vienna, Vienna

Employees

10,000-50,000

Revenue

$10B+ (estimated)

Certifications

ISO 9001

What Janssen-Cilag Pharma GmbH makes

Janssen-Cilag holds ISO 9001 certification and develops marketed medicines including DARZALEX FASPRO®, RYBREVANT FASPRO™, and CAPLYTA® across multiple therapeutic areas.

Certifications

Janssen-Cilag Pharma GmbH is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Latest developments

Company details

As part of Johnson & Johnson, the company operates in automotive, electric-vehicle, and medical sectors with a workforce spanning 10,000–50,000 employees. Janssen-Cilag Pharma GmbH has an estimated 10,000-50,000 employees, and is headquartered in Vienna, Vienna.

Frequently asked questions

What does Janssen-Cilag Pharma GmbH do?

Janssen-Cilag Pharma GmbH, headquartered in Vienna, Austria, is a pharmaceutical division of Johnson & Johnson with 10,000–50,000 employees and over $10 billion in revenue. The company develops medicines across oncology, immunology, neuroscience, cardiovascular and metabolism, pulmonary hypertension, and retina therapies. In 2026, the company secured pharmaceutical supply contracts with Spanish health authorities.

Where is Janssen-Cilag Pharma GmbH headquartered?

Janssen-Cilag Pharma GmbH is headquartered in Vienna, Vienna.

How big is Janssen-Cilag Pharma GmbH?

Janssen-Cilag Pharma GmbH has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).

What certifications does Janssen-Cilag Pharma GmbH hold?

Janssen-Cilag Pharma GmbH lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Vienna, Vienna (HQ)Headquarters · Vienna, Austria
Vienna, Vienna (HQ)Vienna, Vienna, AustriaHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.